Results 71 to 80 of about 340 (163)
Social, Behavioral, and Clinical Risk Factors Are Associated with Clonal Hematopoiesis. [PDF]
Cancer Epidemiol Biomarkers PrevYoung CD, Hubbard AK, Saint-Maurice PF, Chan ICC, Cao Y, Tran D, Bolton KL, Chanock SJ, Matthews CE, Moore SC, Loftfield E, Machiela MJ. +11 moreeuropepmc +1 more sourceImpact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes. [PDF]
Blood AdvNead KT, Kim T, Joo L, McDowell TL, Wong JW, Chan ICC, Brock E, Zhao J, Xu T, Tang C, Lee CL, Abe JI, Bolton KL, Liao Z, Scheet PA, Lin SH. +15 moreeuropepmc +1 more sourceGermline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy. [PDF]
Nat GenetLiu J, Tran D, Xue L, Wiley BJ, Vlasschaert C, Watson CJ, MacGregor HAJ, Zong X, Chan ICC, Das I, Uddin MM, Niroula A, Griffin G, Griffin G, Ebert BL, Mack T, Pershad Y, Sharber B, Berger M, Zehir A, Ptashkin R, Levine RL, Papaemmanuil E, Joseph V, Gao T, Kemel Y, Mandelker D, Stopsack KH, Pharoah PDP, Mukherjee S, Ding L, Cao Y, Walter MJ, Blundell JR, Chatterjee N, Offit K, Godley LA, Link DC, Stadler ZK, Bick AG, Natarajan P, Bolton KL. +41 moreeuropepmc +1 more sourceChanges in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries. [PDF]
Acta OncolJohansson A, Skog A, Johannesen TB, Myklebust TÅ, Kønig SM, Skovlund CW, Mørch LS, Friis S, Kristiansen MF, Pettersson D, Gudmundsdóttir EM, Kristinsdóttir NM, Birgisson H, Irenaeus S, Ahlgren J, Lambe M, Hirvonen E, Pitkäniemi J, Ursin G. +18 moreeuropepmc +1 more sourceDysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans. [PDF]
J Clin Invest, 2021 Le TL, Galmiche L, Levy J, Suwannarat P, Hellebrekers DM, Morarach K, Boismoreau F, Theunissen TE, Lefebvre M, Pelet A, Martinovic J, Gelot A, Guimiot F, Calleroz A, Gitiaux C, Hully M, Goulet O, Chardot C, Drunat S, Capri Y, Bole-Feysot C, Nitschké P, Whalen S, Mouthon L, Babcock HE, Hofstra R, de Coo IF, Tabet AC, Molina TJ, Keren B, Brooks A, Smeets HJ, Marklund U, Gordon CT, Lyonnet S, Amiel J, Bondurand N. +36 moreeuropepmc +1 more sourceDiagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements. [PDF]
Eur J NeurolMancuso M, Bellusci M, Carelli V, de Coo I, Diodato D, Distelmaier F, Hikmat O, Hirano M, Horvath R, Karaa A, Klopstock T, Koenig MK, Kornblum C, La Morgia C, Lopriore P, Martikainen MH, McFarland R, Musumeci O, Pitceathly RDS, Primiano G, Rahman S, Scaglia F, Schaefer A, Schiff M, Semmler L, Lamperti C, Servidei S. +26 moreeuropepmc +1 more sourceClonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). [PDF]
Clin Cancer ResJensen JL, Bobek O, Chan ICC, Miller BC, Hillman DW, Heller G, Druley T, Armstrong AJ, Morris MJ, Milowsky MI, Beltran H, Bolton KL, Coombs CC. +12 moreeuropepmc +1 more sourcePlasma Proteomic Signature Predicts Myeloid Neoplasm Risk. [PDF]
Clin Cancer ResTran D, Beeler JS, Liu J, Wiley B, Chan ICC, Xin Z, Kramer MH, Batchi-Bouyou AL, Zong X, Walter MJ, Petrone GEM, Chlamydas S, Ferraro F, Oh ST, Link DC, Busby B, Cao Y, Bolton KL. +17 moreeuropepmc +1 more source